Long-term outcome of percutaneous radiofrequency ablation in recurrent hepatocellular carcinoma after liver transplantation

References

• Venook AP, Papandreou C, Furuse J, de Guevara LL. (2010). The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist 15:5–13.
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, et al. (2015). Global cancer statistics, 2012. CA Cancer J Clin 65:87–108.
   PubMed Web of Science ®Google Scholar
• Xu DW, Wan P, Xia Q. (2016). Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: a review. World J Gastroenterol 22:3325–34.
   PubMed Web of Science ®Google Scholar
• Morise Z, Kawabe N, Tomishige H, et al. (2014). Recent advances in the surgical treatment of hepatocellular carcinoma. World J Gastroenterol 20:14381–92.
   PubMed Web of Science ®Google Scholar
• Rubin J, Ayoub N, Kaldas F, Saab S. (2012). Management of recurrent hepatocellular carcinoma in liver transplant recipients: a systematic review. Exp Clin Transplant 10:531–43.
   PubMed Web of Science ®Google Scholar
• Chok K. (2015). Management of recurrent hepatocellular carcinoma after liver transplant. World J Hepatol 7:1142–8.
   PubMedGoogle Scholar
• Chok KS, Chan SC, Cheung TT, et al. (2011). Late recurrence of hepatocellular carcinoma after liver transplantation. World J Surg 35:2058–62.
   PubMed Web of Science ®Google Scholar
• Minagawa M, Makuuchi M, Takayama T, Kokudo N. (2003). Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg 238:703–10.
   PubMed Web of Science ®Google Scholar
• Zhou B, Shan H, Zhu KS, et al. (2010). Chemoembolization with lobaplatin mixed with iodized oil for unresectable recurrent hepatocellular carcinoma after orthotopic liver transplantation. J Vasc Interv Radiol 21:333–8.
   PubMed Web of Science ®Google Scholar
• Perkins JD. (2007). Recurrent hepatocellular carcinoma is a problem we need to tackle. Liver Transpl 13:1057–61.
   PubMed Web of Science ®Google Scholar
• Chen MH, Yang W, Yan K, et al. (2004). Large liver tumors: protocol for radiofrequency ablation and its clinical application in 110 patients-mathematic model, overlapping mode, and electrode placement process. Radiology 232:260–71.
   PubMed Web of Science ®Google Scholar
• Yan K, Chen MH, Yang W, et al. (2008). Radiofrequency ablation of hepatocellular carcinoma: long-term outcome and prognostic factors. Eur J Radiol 67:336–47.
   PubMed Web of Science ®Google Scholar
• Chen MH, Wei Y, Yan K, et al. (2006). Treatment strategy to optimize radiofrequency ablation for liver malignancies. J Vasc Interv Radiol 17:671–83.
   PubMed Web of Science ®Google Scholar
• Yang W, Yan K, Wu GX, et al. (2015). Radiofrequency ablation of hepatocellular carcinoma in difficult locations: Strategies and long-term outcomes. World J Gastroenterol 21:1554–66.
   PubMed Web of Science ®Google Scholar
• Kim YS, Lim HK, Rhim H, et al. (2013). Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors. J Hepatol 58:89–97.
   PubMed Web of Science ®Google Scholar
• Huang J, Yan L, Wu H, et al. (2016). Is radiofrequency ablation applicable for recurrent hepatocellular carcinoma after liver transplantation?. J Surg Res 200:122–30.
   PubMed Web of Science ®Google Scholar
• Ho CK, Chapman WC, Brown DB. (2007). Radiofrequency ablation of recurrent hepatocellular carcinoma in a patient after liver transplantation: two-year follow-up. J Vasc Interv Radiol 18:1451–3.
   PubMed Web of Science ®Google Scholar
• Goldberg SN, Grassi CJ, Cardella JF, et al. (2005). Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 235:728–39.
   PubMed Web of Science ®Google Scholar
• Ko HK, Ko GY, Yoon HK, Sung KB. (2007). Tumor response to transcatheter arterial chemoembolization in recurrent hepatocellular carcinoma after living donor liver transplantation. Korean J Radiol 8:320–7.
   PubMed Web of Science ®Google Scholar
• Immordino G, Bottino G, De Negri A, et al. (2014). Predictability and survival in liver replantransplantation: monocentric experience. Transplant Proc 46:2290–2.
   PubMed Web of Science ®Google Scholar
• Masior L, Grat M, Krasnodebski M, et al. (2016). Prognostic factors and outcomes of patients after liver retransplantation. Transplant Proc 48:1717–20.
   PubMed Web of Science ®Google Scholar
• Cho YK, Kim JK, Kim WT, Chung JW. (2010). Hepatic resection versus radiofrequency ablation for very early stage hepatocellular carcinoma: a Markov model analysis. Hepatology 51:1284–90.
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M. American Association for the Study of Liver Diseases (2011). Management of hepatocellular carcinoma: an update. Hepatology 53:1020–2.
   PubMed Web of Science ®Google Scholar
• Wang JH, Wang CC, Hung CH, et al. (2012). Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma. J Hepatol 56:412–18.
   PubMed Web of Science ®Google Scholar
• Choi D, Lim HK, Kim MJ, et al. (2004). Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy 1. Radiology 230:135–41.
   PubMed Web of Science ®Google Scholar
• Yang W, Chen MH, Yin SS, et al. (2006). Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy: therapeutic efficacy on early-and late-phase recurrence. AJR Am J Roentgenol 186:S275–S83.
   PubMed Web of Science ®Google Scholar
• Zhai H, Liang P, Yu XL, et al. (2015). Microwave ablation in treating intrahepatic recurrence of hepatocellular carcinoma after liver transplantation: an analysis of 11 cases. Int J Hyperthermia 31:863–8.
   PubMed Web of Science ®Google Scholar
• Kim SS, Kang TW, Song KD, et al. (2017). Radiofrequency ablation and transarterial chemoembolisation as first-line treatment for recurrent hepatocellular carcinoma or isolated intrahepatic recurrent hepatocellular carcinoma in transplanted livers. Clin Radiol 72:141–9.
   PubMed Web of Science ®Google Scholar
• Toro A, Ardiri A, Mannino M, et al. (2014). Effect of pre- and post-treatment α-fetoprotein levels and tumor size on survival of patients with hepatocellular carcinoma treated by resection, transarterial chemoembolization or radiofrequency ablation: a retrospective study. BMC Surg 14:40.
   PubMed Web of Science ®Google Scholar
• Arrieta O, Cacho B, Morales-Espinosa D, et al. (2007). The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis. BMC Cancer 7:28.
   PubMed Web of Science ®Google Scholar
• Dohi C, Nouso K, Miyahara K, et al. (2016). Potential of alpha-fetoprotein as a prognostic marker after curative radiofrequency ablation of hepatocellular carcinoma. Hepatol Res 46:916–23.
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Imamura H, Matsuyama Y, et al. (2009). Significance of alpha-fetoprotein and des-γ-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy. Ann Surg Oncol 16:2795–804.
   PubMed Web of Science ®Google Scholar
• Germani G, Gurusamy K, Garcovich M, et al. (2011). Which matters most: number of tumors, size of the largest tumor, or total tumor volume?. Liver Transpl 17:S58–S66.
   PubMed Web of Science ®Google Scholar
• Ng KK, Poon RT, Lo CM, et al. (2008). Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma. J Gastrointest Surg 12:183–91.
   PubMed Web of Science ®Google Scholar
• Zheng S, Chen Y, Liang T, et al. (2006). Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B Immunoglobulin prophylaxis. Liver Transpl 12:253–8.
   PubMed Web of Science ®Google Scholar
• Wu CY, Chen YJ, Ho HJ, et al. (2012). Association between nucleoside analogues and risk of hepatitis B virus–related hepatocellular carcinoma recurrence following liver resection. JAMA 308:1906–13.
   PubMed Web of Science ®Google Scholar